20.01.2015 Views

View - ResearchGate

View - ResearchGate

View - ResearchGate

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

242 Arnau et al.<br />

4. Desalting is necessary to remove imidazole that would otherwise inhibit DAPase<br />

activity during tag removal.<br />

5. DAPase requires the presence of a reducing thiol group for activity. It is<br />

thought that at physiological pH, cysteamine and its oxidized form cystamine<br />

act as a hydrogen donor for the reduction of disulfides in the enzymes.<br />

Therefore, it is recommended to use freshly prepared enzyme cocktails with<br />

cysteamine. Similarly, pGAPase bound to IMAC requires activation using<br />

cysteamine prior to running the sample and after binding of the enzyme to<br />

IMAC.<br />

6. Enzyme activation by cysteamine is performed in small volumes to reduce the<br />

amount needed.<br />

7. Tag sequences containing Asp or Glu can only be digested at acidic pH, while<br />

sequences containing His require pH above 6. Therefore, His-tag sequences<br />

containing Glu or Asp can only be processed at pH 6–6.5.<br />

8. Especially for upscaling purposes, it is important to reduce the amount of enzyme<br />

used for tag removal. One approach is to run the cleavage at 4°C overnight<br />

(see Fig. 5).<br />

9. If the target protein concentration is 1–2 mg/ml, then 1 unit pGAPase per mg<br />

of protein is recommended. For lower concentrations of target protein, higher<br />

amounts of pGAPase are required, for example, at 0.75 mg/ml, 2 units/mg<br />

pGAPase should be used.<br />

10. The flow rate has great impact in the degree of completion of pyroglutamyl<br />

removal. It is therefore not recommended to use higher flow rates.<br />

References<br />

1. Derewenda, Z.S. (2004) The use of recombinant methods and molecular engineering<br />

in protein crystallization. Methods 34, 354–363.<br />

2. Liew, O.W., Ching Chong, J.P., Yandle, T.G. and Brennan, S.O. (2005) Preparation<br />

of recombinant thioredoxin fused N-terminal proCNP: analysis of enterokinase<br />

cleavage products reveals new enterokinase cleavage sites. Protein Expr. Purif. 41,<br />

332–340.<br />

3. He, M., Jin, L. and Austen B. (1993) Specificity of factor Xa in the cleavage of<br />

fusion proteins. J. Protein Chem. 12, 1–5.<br />

4. Pedersen, J., Lauritzen, C., Madsen, M.T. and Dahl, S.W. (1999) Removal of N-<br />

terminal polyhistidine tags from recombinant proteins using engineered aminopeptidases.<br />

Protein Expr. Purif. 15, 389–400.<br />

5. TAGZyme manual (2003). Available from Qiagen at http://www1.qiagen.com/<br />

literature/handbooks/PDF/Protein/Purification/QXP_TAGZyme/1024037_HBQXPT<br />

AGZyme_032003.pdf<br />

6. Hirel, P.H., Schmitter, J.M., Dessen, P., Fayat, G. and Blanquet, S. (1989) Extent<br />

of N-terminal methionine excision from Escherichia coli proteins is governed by<br />

the side-chain length of the penultimate amino acid. Proc. Natl. Acad. Sci. U. S. A.<br />

86, 8247–8251.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!